Author: admin
In this week’s cannabis news round-up, senate democrats urge President Biden to rethink federal cannabis restrictions; clinical trial reveals reduced anxiety levels linked to cannabis; and a federal judge dismisses lawsuit challenging Mississippi’s cannabis advertising restrictions. PHOTO vgm8383 Senate Democrats Urge Biden to Rethink Cannabis Descheduling Senate Democrats have increased the pressure on the Biden administration to relax federal cannabis restrictions. In a letter addressed to the Drug Enforcement Administration (DEA) this week, they urged reconsideration of cannabis descheduling, which has been classified at the federal level for over fifty years. The letter, signed by a group of 12 senators led by…
KS medical marijuana concerns; Irish cannabis vote; MO psilocybin; New THC testing method; NH legalization Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Your support makes Marijuana Moment possible… Subscribers who value this daily dispatch enough to show their support with a few dollars help us keep doing this. Please chip in and help ensure Marijuana Moment’s continued operations.https://www.patreon.com/marijuanamoment/ TOP THINGS TO KNOWSens. Elizabeth Warren (D-MA) and John Fetterman (D-PA) led a group of 12 senators who sent a letter telling…
What does cannabis, coca leaf, and all coffee have in common? They all contain alkaloids, a powerful group of medicinal compounds found in plants around the world. While little is presently known about cannabis alkaloids, they are suspected to possess impressive medical benefits like other plant alkaloids. Alkaloids vs. Cannabinoids Alkaloids are “one of the most common groups of chemicals that [have] medicinal properties found in plants,” commonly used alkaloids include “morphine, cocaine, nicotine, caffeine, quinine, ephedrine, and many more.” They derive their name, alkaloid, from the word alkali, chemicals that react like bases, counteracting acids. Usually found in the…
NY gov: marijuana law a “disaster”; CA psychedelics; HI legalization; VA legal cannabis sales; KY HB420 bill; AZ psilocybin Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Your support makes Marijuana Moment possible… Free to read (but not free to produce)! We’re proud of our newsletter and the reporting we publish at Marijuana Moment, and we’re happy to provide it for free. But it takes a lot of work and resources to make this happen. If you value Marijuana Moment, invest…
In this week’s cannabis news round-up, Denver hits half-billion mark in cannabis taxes and fees; New York cannabis office releases fact sheet to bust cannabis and fentanyl myths; cannabis use common for work-related injury recovery in Canada, declines in US workers’ compensation filings following legalization; and Cann launches in DTLA Soho House. PHOTO Cris Gonzales Denver Hits Half-Billion Mark in Cannabis Taxes and Fees It’s reported that Denver has surpassed $500 million in cannabis tax revenue, a milestone reached in August 2023. The city’s Excise & Licenses department began tracking cannabis tax revenue in 2010 when medical dispensaries were first…
The Department of Justice has rescinded a DEA decision to fire a special agent who was let go due to a positive reading for CBD on a drug test. DEA special agent Anthony L. Armour will be re-hired as a special agent and be reimbursed for back pay and legal expenses after a years-long court battle that stretches back to 2019 when a routine drug test showed he had been using CBD, which Armour maintained in court was for the purpose of treating chronic pain in lieu of highly-addictive opioid based painkillers. “I’m excited to be getting back to work…
The U.S. Food and Drug Administration last week announced the voluntary recall of a medicine used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy after the manufacturer of the drug revealed that the wrong pills were found in packages of the medication. The recall covers one lot of the drug Zenzedi, an ADHD and narcolepsy medication manufactured by Massachusetts-based Azurity Pharmaceuticals. In a notice about the recall, the FDA noted that a pharmacist had reported finding pills of an antihistamine, carbinoxamine maleate, in a package of Zenzedi. The voluntary recall was announced by Azurity on January 24 and covers…
In this week’s cannabis news round-up, a new survey suggests cannabis rescheduling could boost President Biden’s ratings; New York’s delayed regulations cast shadow on homegrown hopes; and Maine considers bill to establish cannabis social clubs for tourists and residents. PHOTO Elvert Barnes Cannabis Rescheduling Could Boost President Biden’s Approval Rating If President Biden wants to improve his approval rating, he should make the move and reschedule cannabis, says a new nationwide survey. According to the survey by Lake Research Partners, such a change would boost his ratings by a considerable 11 points overall, including a sizeable 11-point positive shift among…
In this week’s cannabis news round-up, Oregon’s Rep. Blumenauer announces retirement after 27 years in Congress; New York expands medical cannabis retail licenses to MSOs; and Switzerland launches first legal cannabis dispensary in Europe. Rep. Blumenauer introducing the STATES Act in 2019. PHOTO Earl Blumenauer/Twitter Rep. Blumenauer (D-OR) Retiring After 27 Years in Congress Earl Blumenauer, a Democrat from Oregon who has served in the US House of Representatives for 27 years, announced on Monday that he will not seek re-election. In a press release, he said it was a “difficult decision” but that “it’s time to continue my life’s mission…
In this week’s cannabis news round-up, Ohio becomes the 24th state to legalize adult use cannabis; hemp-derived cannabinoid sales outpace legal cannabis; and cannabis businesses challenge federal prohibition in landmark lawsuit. PHOTO Ɱ Ohio Becomes Latest State to Legalize Adult Use Cannabis Buckeye State voters have approved a measure legalizing adult use cannabis, making Ohio the 24th state to adopt such a policy. This decision marks a departure from the stance of Republican legislative leaders, who had previously opposed the legalization of cannabis for non-medical purposes. The passing of Issue 2 sends a clear message that Ohioans are ready to…